Churchill Hospital — Oxford

Public research footprint of Churchill Hospital, compiled from the ClinicalTrials.gov public registry.

474

Registered studies

140

Active

Recruiting now

248

Completed

Stopped or withdrawn

Most-studied conditions

Locally Advanced Solid Tumors · Relapsed or Refractory Multiple Myeloma (RRMM) · Relapsed/Refractory Peripheral T-Cell Lymphoma · Lymphoma, Large B-Cell, Diffuse

Recently updated registry entries

NCT06152575 — MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People… (Recruiting)
NCT06150157 — A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated… (Recruiting)
NCT05490446 — A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Churchill Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.